Novartis AG 2021 Integrated Report
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2021
Type: Integrated Report
Pages: 61
The report describes Novartis' 2021 performance, including USD 51.6 billion in net sales and continued growth in key medicines. It highlights access approaches reaching 56.2 million patients and the milestone of 1 billion antimalarial treatments delivered since 1999. Environmental progress included a 34% reduction in Scope 1 and Scope 2 greenhouse gas emissions versus the 2016 baseline, alongside a net-zero value-chain commitment for 2040. ESG governance was strengthened through Board committee oversight and an executive Trust & Reputation Committee.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.